The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / RheumPAC Members Speak Out on the Importance of Political Action Committees

RheumPAC Members Speak Out on the Importance of Political Action Committees

July 5, 2018 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

People can support causes, committees, campaigns, etc. in infinite ways. Members of the ACR/ARHP can see their efforts magnified via an investment in the ACR’s political action committee, RheumPAC. Your contribution goes directly to help support rheumatology and rheumatologists around the country.

You Might Also Like
  • RheumPAC: How the ACR’s Non-Partisan Political Action Committee Works
  • RheumPAC Calls on the ACR, ARHP Members to Support Advocacy Efforts
  • RheumPAC: Answers to FAQs
Also By This Author
  • Sessions to Check Out During the 2018 ACR/ARHP Annual Meeting

Proof of any group’s success can be seen in the satisfaction of its members. If you haven’t yet invested in RheumPAC, two members who believe in the committee’s work share their thoughts on why it’s important to invest.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Fotios Koumpouras, MD
In today’s political climate, we find that local communities and business groups must keep up with the pace and even outpace the ever-changing political agenda. This is particularly true in the medical industry, where rapidly changing political agendas, reimbursement laws and vacillating payer mixes make it difficult to understand what one individual can do to [effect] change and be successful as a practicing rheumatologist. We have seen how campaign support of elected officials by various lobbyists and political action groups affects government policies. To be heard, you need to get involved.

Being part of RheumPAC allows your voice to be magnified in unison with other rheumatologists. RheumPAC has facilitated change, such as MACRA flexibility, where CMS has agreed to add options to avoid penalties, and the passage of H.R. 5001 and S. 2822, allowing providers in the Medicare EHR Incentive Program to report to a 90-day reporting period in 2017 rather than a full calendar year. RheumPAC helped advocate for the successful defeat of CMS’s Part B demonstration project, which would have reduced reimbursement to providers for expensive infusion treatments, and for the increase in NIH funding in 2017. On the state level, we [helped] pass six biosimilar bills and four step therapy laws, stopped a coverage change proposed by a payer in North Carolina for steroid injections and got a down-coding decision reversed in the Palmetto MAC region.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Through support of RheumPAC, you can be assured that your investment will support legislation that improves the practice of rheumatology.

John McDougall, MD
Clinicians’ perspectives are critical to efforts made toward designing and reforming the U.S. healthcare system. Whether acting collectively to implement healthcare measures, or individually through direct patient care, clinicians can help both industry and government responsibly spend our limited healthcare dollars. RheumPAC, although representing a small subspecialty, has a big impact by helping focus, amplify and convey the important messages specific to rheumatology.

So much of what affects our patients—and our practice—comes as the direct result of federal and state policy. As a rheumatology fellow in training, I give to RheumPAC because I see the difference it makes. RheumPAC helps me get the attention of my elected representatives on a number of wide-ranging issues, from Medicare payment reform to transparency in drug pricing to state requirements for step therapy. Most importantly, RheumPAC’s nonpartisan approach helps us all focus on what matters most—the needs of our patients.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: From the College, Opinion, Rheuminations Tagged With: ACR’s political action committee, Fotios Koumpouras, John McDougall, RheumPAC, RheumPAC members

You Might Also Like:
  • RheumPAC: How the ACR’s Non-Partisan Political Action Committee Works
  • RheumPAC Calls on the ACR, ARHP Members to Support Advocacy Efforts
  • RheumPAC: Answers to FAQs
  • RheumPAC: It’s Not About Politics

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.